Literature DB >> 6705453

Plasma protein binding of drugs after severe burn injury.

J A Martyn, D R Abernethy, D J Greenblatt.   

Abstract

Plasma protein binding in seven severely burned (35% to 85% of body) patients 1 to 25 days after burn injury was examined for two drugs: diazepam (DZ), which binds mainly to serum albumin (ALB), and imipramine (IMI), which binds primarily to alpha 1-acid glycoprotein (AAG). Protein binding was determined by equilibrium dialysis, and AAG concentrations were measured by radial immunodiffusion. AAG concentrations increased from 36 to 99 mg/dl (day 1) to 221 to 268 mg/dl (days 5 to 20). The IMI free fraction values decreased from 11.2%-19.7% to 5.5%-7.8% and correlated well with AAG concentrations. IMI free fraction values were lower in burned patients (10.8% +/- 0.8%) than in healthy controls (15.3% +/- 0.7%). In contrast, DZ free fraction did not correlate with AAG or ALB concentrations. The DZ free fraction ranged from 1.5% to 8.04%, and changes in a given individual did not relate to time after injury. Free fraction of DZ was higher in the burned population (3.5% +/- 0.37%) than in healthy controls (1.25% +/- 0.05%). Basic drugs that are highly bound to AAG may show progressive, increased binding after burn injury, whereas drugs binding to ALB may decrease after burn injury. Such binding changes can alter the interpretation of total serum or plasma drug concentrations.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6705453     DOI: 10.1038/clpt.1984.73

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  20 in total

Review 1.  Age-related changes in protein binding of drugs: implications for therapy.

Authors:  M K Grandison; F D Boudinot
Journal:  Clin Pharmacokinet       Date:  2000-03       Impact factor: 6.447

Review 2.  Antiepileptic-induced resistance to neuromuscular blockers: mechanisms and clinical significance.

Authors:  Sulpicio G Soriano; J A Jeevendra Martyn
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

Review 3.  Disease-induced variations in plasma protein levels. Implications for drug dosage regimens (Part II).

Authors:  R Zini; P Riant; J Barré; J P Tillement
Journal:  Clin Pharmacokinet       Date:  1990-09       Impact factor: 6.447

4.  Analysis of the five glycosylation sites of human alpha 1-acid glycoprotein.

Authors:  M J Treuheit; C E Costello; H B Halsall
Journal:  Biochem J       Date:  1992-04-01       Impact factor: 3.857

5.  Protein binding of clindamycin in sera of patients with AIDS.

Authors:  J F Flaherty; G Gatti; J White; J Bubp; M Borin; J G Gambertoglio
Journal:  Antimicrob Agents Chemother       Date:  1996-05       Impact factor: 5.191

6.  Colistin pharmacokinetics in burn patients during continuous venovenous hemofiltration.

Authors:  Kevin S Akers; Matthew P Rowan; Krista L Niece; Ian J Stewart; Katrin Mende; Jason M Cota; Clinton K Murray; Kevin K Chung
Journal:  Antimicrob Agents Chemother       Date:  2014-10-13       Impact factor: 5.191

7.  The plasma protein binding of basic drugs.

Authors:  P A Routledge
Journal:  Br J Clin Pharmacol       Date:  1986-11       Impact factor: 4.335

8.  Changes in the concentration of serum alpha 1-acid glycoprotein in epileptic patients.

Authors:  K Morita; A Yamaji
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

Review 9.  Acute and perioperative care of the burn-injured patient.

Authors:  Edward A Bittner; Erik Shank; Lee Woodson; J A Jeevendra Martyn
Journal:  Anesthesiology       Date:  2015-02       Impact factor: 7.892

Review 10.  Influence of burns on pharmacokinetics and pharmacodynamics of drugs used in the care of burn patients.

Authors:  Benoit Blanchet; Vincent Jullien; Christophe Vinsonneau; Michel Tod
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.